Anthem Biosciences Ltd. (ANTHEM) Share Price Hits Fresh 52-Week High
- August 17, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Ltd. Share Price stood at Rs 898.25, up 0.9% today after hitting a fresh 52-week high of Rs 903.15. Market capitalisation was Rs 50,157.4 crore.
Anthem Biosciences Ltd. Share Price was at Rs 898.25 on 17 August 2026 at 9:58 AM IST, up Rs 8 or 0.9% from the previous close of Rs 890.25, after touching a fresh 52-week high of Rs 903.15. The company’s market capitalisation stood at Rs 50,157.4 crore, placing it firmly on the radar in today’s Stock Market Today and Share Market Today watchlists.
The verified data confirms the one-year high event and shows that the stock opened at Rs 893.05, moved in a day range of Rs 890.55 to Rs 903.15, and generated turnover of Rs 2.81 crore on volume of 31,264 shares. That makes Anthem Biosciences Ltd. Stock News relevant because the move combines a fresh yearly high with measurable trading activity, even though the supplied data does not establish a company-specific catalyst for why the stock is moving.
For investors tracking 52 Week High Stocks, the immediate questions are straightforward: what exactly happened in price action, how do the available fundamentals frame the move, and how does the stock compare with peers and the Healthcare sector benchmark. In this Univest analysis, the focus stays on verified price, valuation and sector data rather than speculation.
Anthem Biosciences Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 898.25 |
| Previous Close | Rs 890.25 |
| Today's Change | +Rs 8 (+0.9%) |
| Day Open | Rs 893.05 |
| Fresh 52-Week High | Rs 903.15 |
| Day Low | Rs 890.55 |
| Current Volume | 31,264 |
| Turnover | Rs 2.81 crore |
| Market Capitalisation | Rs 50,157.4 crore |
Anthem Biosciences Ltd. (ANTHEM) traded at Rs 898.25. versus the previous close of Rs 890.25, a rise of 0.9%. The stock opened at Rs 893.05, reached Rs 903.15, touched Rs 890.55. Reported volume was 31,264.
Anthem Biosciences Ltd. Share Price Today shows a modest but notable intraday gain that culminated in a fresh 52-week peak. The stock rose Rs 8 from Rs 890.25 to Rs 898.25, traded as high as Rs 903.15, and stayed above its day open of Rs 893.05 while holding a day low of Rs 890.55.
That intraday structure suggests the stock remained firm after the open and managed to print a new one-year high during the session. The difference between the previous close of Rs 890.25 and the day high of Rs 903.15 underlines the breakout nature of the move, while the last traded price of Rs 898.25 shows the stock retained most of the day’s gains rather than giving up the entire advance.
Turnover of Rs 2.81 crore and traded volume of 31,264 shares indicate active participation in Anthem Biosciences Ltd. Share Price Today. In Market News terms, this places the stock among notable Market Movers and Stocks in News because a fresh 52-week high often draws added attention from traders tracking Price Action and breakout screens.
The supplied data therefore answers what happened today: Anthem Biosciences Ltd. Share Price made a fresh 52-week high at Rs 903.15 and was still trading above the previous close. What the data does not establish is a verified company-specific trigger. That shifts attention toward whether valuation, profitability and sector positioning help explain why the stock is attracting investor interest.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 50,157.4 crore |
| P/E Ratio | 184.72x |
| P/B Ratio | 0.45x |
| ROE | -2.89% |
| ROCE | -0.26% |
Anthem Biosciences Ltd. was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 184.72x |
| Benchmark Median P/E | 21.1x |
| Benchmark Average P/E | 49.38x |
| Benchmark P/E Range | 0x to 1,603.4x |
| Company P/B Ratio | 0.45x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.71% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.15% |
| Company Market Capitalisation | Rs 50,157.4 crore |
| Benchmark Median Market Cap | Rs 135.27 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,985.15 | 184.72 | 0.45 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,827.67 | 68.16 | 6.74 | 18.65 | 22.17 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,645.37 | 46.15 | 1.77 | -0.78 | 8.31 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,612.26 | 34.27 | 7.07 | -2.6 | 16.92 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,559.68 | 58.41 | 8.73 | 11.42 | 13.15 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 50,157.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences Ltd.
The stock is drawing attention because a fresh 52-week high combined with a large market capitalisation naturally places it on trader and investor screens. The verified dataset highlights several reasons why Anthem Biosciences Ltd. Latest News and Anthem Biosciences Ltd. Share News are being watched today.
- Fresh price milestone: the stock touched Rs 903.15, its new 52-week peak, before trading at Rs 898.25.
- Positive daily move: Anthem Biosciences Ltd. Share Price Today was up Rs 8 or 0.9% over the previous close of Rs 890.25.
- Active trading: turnover was Rs 2.81 crore with volume of 31,264 shares.
- Large quoted size: market capitalisation stood at Rs 50,157.4 crore, far above the supplied sector averages.
- Valuation contrast: P/E at 184.72 is above Healthcare benchmark norms, while P/B at 0.45 is below them.
- Profitability watchpoint: ROE of -2.89% and ROCE of -0.26% sit below the sector median and average figures.
About Anthem Biosciences Ltd.
Anthem Biosciences Ltd. is being tracked in the supplied dataset within the Healthcare sector. The current market discussion around Anthem Biosciences Ltd. NSE and Anthem Biosciences Ltd. BSE references is centred less on a detailed business update and more on a market event: the stock reaching a fresh 52-week high.
Based on the verified data used for this Univest article, the company stands out in the Healthcare pack because of its quoted market capitalisation of Rs 50,157.4 crore, which is substantially above the benchmark summary figures provided for 201 same-sector companies. The peer set attached to the stock also places it alongside Healthcare names such as Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals.
For readers following Anthem Biosciences Ltd. Stock News, the most important current takeaway is that the company is now part of the active 52-week high conversation within Healthcare, and that its market valuation, sector position and peer comparisons are likely to remain closely monitored.
Track Anthem Biosciences Ltd. Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
On Univest, investors can track Anthem Biosciences Ltd. Share Price Live, daily stock performance, 52-week levels, market capitalisation and valuation ratios in one place. For users following Anthem Biosciences Ltd. Share Price Today, Univest helps organise price action, sector context, peer comparison and broader market insights in a structured format.
That matters on sessions like this, when Anthem Biosciences Ltd. Share Price reaches a fresh one-year high and enters the list of 52 Week High Stocks and potential Momentum Stocks. Univest coverage is designed to help readers monitor verified numbers, compare them with sector benchmarks and keep track of key stock updates without turning data points into unsupported conclusions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Anthem Biosciences Ltd. Share Price today?
Ans. Anthem Biosciences Ltd. Share Price was Rs 898.25 on 17 August 2026 at 9:58 AM IST. The stock was up Rs 8, or 0.9%, from the previous close of Rs 890.25 after touching a fresh 52-week high.
What is the fresh 52-week high of Anthem Biosciences Ltd.?
Ans. The fresh 52-week high of Anthem Biosciences Ltd. was Rs 903.15. The stock reached that level during the session and later traded at Rs 898.25, keeping most of the day’s gain intact above the previous close of Rs 890.25.
How much did Anthem Biosciences Ltd. rise today?
Ans. Anthem Biosciences Ltd. rose by Rs 8 in absolute terms and 0.9% in percentage terms versus the previous close. The move took the stock from Rs 890.25 to Rs 898.25 while also marking a new one-year high.
What does today’s price action show for Anthem Biosciences Ltd.?
Ans. Today’s price action shows the stock opened at Rs 893.05, hit a low of Rs 890.55 and a high of Rs 903.15. That range indicates Anthem Biosciences Ltd. held firm intraday while registering a fresh 52-week peak.
What was the trading volume and turnover in Anthem Biosciences Ltd. today?
Ans. Anthem Biosciences Ltd. recorded volume of 31,264 shares and turnover of Rs 2.81 crore in the supplied session data. Those figures confirm active market participation alongside the stock’s move to a fresh 52-week high.
What is the market capitalisation of Anthem Biosciences Ltd.?
Ans. Anthem Biosciences Ltd. had a market capitalisation of Rs 50,157.4 crore in the supplied data. That is far above the Healthcare sector benchmark average of Rs 456.49 crore and median of Rs 135.27 crore shown in this analysis.
Is Anthem Biosciences Ltd. expensive compared with the Healthcare sector on P/E?
Ans. On the supplied numbers, Anthem Biosciences Ltd. trades at a P/E of 184.72 versus the Healthcare sector median of 21.1 and average of 49.38. That places the stock well above the benchmark’s central valuation levels on earnings.
How does Anthem Biosciences Ltd. compare on P/B ratio?
Ans. Anthem Biosciences Ltd. has a P/B ratio of 0.45. That is below the Healthcare sector median of 1.9 and average of 2.3, so the stock looks cheaper on book-value valuation than the benchmark sector’s central levels.
What do the ROE and ROCE figures indicate for Anthem Biosciences Ltd.?
Ans. The supplied profitability ratios show ROE at -2.89% and ROCE at -0.26% for Anthem Biosciences Ltd. Both figures are below the Healthcare sector medians of 10.71 and 13.15 respectively, indicating weaker reported return metrics.
Why is Anthem Biosciences Ltd. in focus today?
Ans. Anthem Biosciences Ltd. is in focus because the stock hit a fresh 52-week high of Rs 903.15 and traded at Rs 898.25. Its large market capitalisation and unusual mix of high P/E and low P/B add further attention.
